These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9333066)

  • 1. Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.
    Scaglione F; De Martini G; Peretto L; Ghezzi R; Baratelli M; Arcidiacono MM; Fraschini F
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2292-4. PubMed ID: 9333066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
    Loffreda A; Lampa E; Lucarelli C; Amorena M; Contaldi C; Calderaro V; Rossi F
    Chemotherapy; 1999; 45(1):1-7. PubMed ID: 9876203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of third-generation cephalosporins into human peritoneal tissue.
    Berger SA; Dan M; Serour F; Gorea A; Levenberg A; Krispin M
    Chemotherapy; 1989; 35(5):326-9. PubMed ID: 2676403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preincisional single-dose ceftriaxone for the prophylaxis of surgical wound infection.
    Chalkiadakis GE; Gonnianakis C; Tsatsakis A; Tsakalof A; Michalodimitrakis M
    Am J Surg; 1995 Oct; 170(4):353-5. PubMed ID: 7573727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.
    Mazzei T; Novelli A; Esposito S; Fallani S; Noviello S; Cassetta MI; Conti S; Periti P
    J Chemother; 2000 Aug; 12(4):306-13. PubMed ID: 10949980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery.
    Gergs U; Clauss T; Ihlefeld D; Weiss M; Pönicke K; Hofmann GO; Neumann J
    J Pharm Pharmacol; 2014 Nov; 66(11):1552-8. PubMed ID: 24941934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate.
    Scaglione F; Raichi M; Fraschini F
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():1-10. PubMed ID: 2228838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B; Namour F; Logeais C; Coussediere D; Rivault O; Bryskier A; Surjus A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes.
    Goonetilleke AK; Dev D; Aziz I; Hughes C; Smith MJ; Basran GS
    J Antimicrob Chemother; 1996 Dec; 38(6):969-76. PubMed ID: 9023644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone.
    Lovering AM; Walsh TR; Bannister GC; MacGowan AP
    J Antimicrob Chemother; 2001 Apr; 47(4):483-6. PubMed ID: 11266427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ceftriaxone in neonatal foals.
    Ringger NC; Brown MP; Kohlepp SJ; Gronwall RR; Merritt K
    Equine Vet J; 1998 Mar; 30(2):163-5. PubMed ID: 9535074
    [No Abstract]   [Full Text] [Related]  

  • 13. High-performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma.
    Hakim L; Bourne DW; Triggs EJ
    J Chromatogr; 1988 Jan; 424(1):111-7. PubMed ID: 3366822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis.
    Müller M; Rohde B; Kovar A; Georgopoulos A; Eichler HG; Derendorf H
    J Clin Pharmacol; 1997 Dec; 37(12):1108-13. PubMed ID: 9506005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of time interval on tissue concentrations of cephalosporins after tourniquet inflation. Highest levels achieved by administration 20 minutes before inflation.
    Dounis E; Tsourvakas S; Kalivas L; Giamaçellou H
    Acta Orthop Scand; 1995 Apr; 66(2):158-60. PubMed ID: 7740948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g.
    Nilsen OG; Rennemo F; Rennemo R; Lenfant B
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():71-5. PubMed ID: 2074254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open, controlled, randomized study on the efficacy and safety of cefodizime single daily dose versus two daily doses and versus ceftriaxone single daily dose in patients with acute purulent bronchitis and acute purulent exacerbation of chronic bronchitis.
    Zanussi C; Cocuzza G
    J Chemother; 1995 Dec; 7(6):535-42. PubMed ID: 8667039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.